First Trust NYSE Arca Biotech ETF
(NYSE ARCA: FBT)
AdChoices
96.22
+1.20
+1.26%
:

Open

95.14

Net Assets

1.51B

Day's Range

94.73-96.55

52 week range

60.78-96.55

Category

Health

Vol (3-Month Avg.)

148.93k

Yield

0.00%

Morningstar Risk

High

AdChoices
Performance
Returns %
Key statistics
  • Composition
  • Performance
  • Top Holdings
  • Key Statistics
Composition
Top Equity Sector Holding
Equity Investment Style
The two dimensions of the Fund Style box measure the average size of companies that have been in the ETF, from the top to bottom, and the average valuation characteristics of the ETF's past stock holdings, from left to right.

PERFORMANCE

  • Total Return %

  • 1 Day

  • 1 Week

  • 1 Month

  • 3 Months

  • 1 Year

  • 3 Years

  • 5 Years

    • FBT

    • 2.59

    • 7.21

    • 4.19

    • 14.12

    • 46.84

    • 39.96

    • 28.99

    • Category(Health)

    • 1.83

    • 6.34

    • 1.61

    • 5.15

    • 27.17

    • 29.48

    • 23.14

    • Rank in Category

    • 13

    • 13

    • 19

    • 1

    • 1

    • 8

    • 19

    MORNINGSTAR RATING

    • Years

    • Return

    • Risk

    • Rating

      • 3 Years

      • Above Average

      • High

      • ★★★★
      • 5 Years

      • High

      • High

      • ★★★★
      • 10 Years

      • -

      • -

      • -

      • Overall

      • High

      • High

      • ★★★★

      TOP HOLDINGS

      • Name

      • % Portfolio Weight

      • Shares Held

      • Change

        • Celgene Corp

        • 3.57

        • 595,437

        • 11,844

        • Alexion Pharmaceuticals Inc

        • 3.54

        • 318,483

        • 6,335

        • Illumina Inc

        • 3.54

        • 318,494

        • 6,335

        • NPS Pharmaceuticals Inc

        • 3.49

        • 2,005,275

        • 39,879

        • Amgen Inc

        • 3.46

        • 392,841

        • 7,812

        • Cubist Pharmaceuticals Inc

        • 3.45

        • 796,607

        • 15,841

        • Incyte Corp Ltd

        • 3.44

        • 1,048,003

        • 20,839

        • Myriad Genetics Inc

        • 3.40

        • 1,498,484

        • 29,799

        • Pharmacyclics Inc

        • 3.39

        • 467,899

        • 9,303

        • Nektar Therapeutics Inc

        • 3.35

        • 4,232,226

        • 84,161

        CATEGORY

        • Name

        • FBT

        • Category

          • Avg. Market Cap USD (M)

          • 8,887.86

          • 27,214.31

          • Expense Ratio

          • 0.60%

          • 0.44%

          • Net Assets

          • 1.51B

          • 1.06B

          • Price/Prospective Earnings

          • 22.94

          • 21.83

          • Price/Book

          • 6.46

          • 4.82

          • Price/Sales

          • 7.51

          • 3.25

          • Price/Cash Flow

          • 12.91

          • 19.29

          • Dividend Yield

          • 0.39%

          • 0.39

          Profile

          Name of Issuer

          First Trust

          Expenses

          0.60%

          The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.

          Inception

          6/19/2006